Fiscal Year End | Company Status | Exempt Flag |
December 31 | Trading | N |
|
|
|
|
|
Incorporation Locations |
Inc. Date | Expiry Date | Country | Region | Description |
26/Mar/2012 | | Canada | Alberta | |
|
|
Exchange Filing Office |
Location |
Calgary Regional Service Office |
|
| |
Business Type(s) |
Primary/Secondary | Business Type | Details |
Primary
| Consumer Products - Biotechnology/Pharmaceuticals
| News Release January 12, 2015-Hemostemix is a public clinical-stage company that develops and commercializes innovative blood-derived cell therapies for medical conditions not adequately addressed by current treatments.
|
|
|
Securities |
Symbol | Security Name | Market | Status |
HEM | Hemostemix Inc. | TSX Venture | TRADING |
|
|
Name History | From | To |
Hemostemix Inc. | 27/Nov/2014 | Present |
|
|
Company Facts Reconciliation |
Subject | Date Returned |
Spring 2015 CFR | Not Received |
|
|
|
|